John Hancock medical resignation of several senior executives in cap ST risks remain jcuv是什么车

Nov 16, 2017 // By:feichang // No Comment

John Hancock medical resignation of several senior executives in cap "*ST" risks remain hot column capital flows thousands of thousands of stocks the latest Rating Rating diagnosis simulated trading client sina finance App: Live on-line blogger to tutor you say stocks contest 60 million was the Shenzhen Stock Exchange inquiry, the actual control of Que Wenbin suspected of violating securities laws laws and regulations are examiner Zhang Chunnan, Zhang Jiazhen September 1st, John Hancock medical group Limited by Share Ltd (hereinafter referred to as the "John Hancock medical", 002219.SZ) announced that the February 1st, the company and the controlling shareholder, actual controller Que Wenbin received Chinese Securities Regulatory Commission (hereinafter referred to as the "Commission") the "investigation notice", for alleged violations of securities laws and regulations are filing audit. John Hancock medical said that there are significant violations of information disclosure as the company, the company’s shares may be the Shenzhen stock exchange delisting risk warning and suspend the listing. John Hancock medical including the chairman, senior managers, securities affairs representative, many executives have resigned also led to the Shenzhen stock exchange, and require the company to respond to the specific reasons for the resignation of the staff, will have a significant impact on the daily production and business activities of the company, that the company intends to take measures to deal with such problems. In September 8th, John Hancock Medical Board Secretary Cao Wei in an "Chinese business newspaper" interview with reporters said that at present the company’s business is normal, and did not have a significant adverse impact on the company’s daily operations, the company will actively cooperate with the investigation of Que Wenbin and the work of the Commission, the relevant departments have not received conclusive opinions, if you receive will timely disclosure. Executives unrest from the beginning of this year, John Hancock medical and Que Wenbin actual control of the company suspected of violating securities laws and regulations by the Commission to initiate an investigation, the company has experienced executives turbulent period, and facing the risk is subject to delisting risk warning ". According to the company announcement, February 1st, John Hancock medical and the controlling shareholder, actual controller Que Wenbin received the commission the "investigation notice" (Shanghai card No. 2016123, Shanghai special investigation special investigation Certificate No. 2016124). Due to the company’s information disclosure of alleged violations of securities laws and regulations, the alleged violation of the securities laws and regulations, the Commission decided to conduct checks on the company and Que Wenbin. John Hancock medical said, so if the company by the Commission administrative penalties, and administrative penalty decision in the book is considered a material violation or suspicion of illegal disclosure, non disclosure of important information on the crime shall be transferred to the public security organs, the company will hit major information disclosure violations, the company’s stock transaction will be implemented delisting risk warning. Affected by this, the company ushered in the executive team turbulence period, a number of executives have left. This also led to the Shenzhen stock exchange, and require the company to respond to the specific reasons for the resignation of the staff, will have a significant impact on the daily production and business activities of the company, that the company intends to take measures to deal with such problems. John Hancock medical in the Shenzhen stock exchange, "attention" a letter to reply on相关的主题文章:

About feichang

Browse Archived Articles by feichang

Related

Sorry. There are no related articles at this time.